GENEVA, Dec. 29 -- DUALITY BIOLOGICS (SUZHOU) CO., LTD. (Unit 301, Building 3, Zone B, Biomedical Industrial Park Phase 3, No. 99, Jingu Road, Suzhou Industrial ParkSuzhou, Jiangsu 215028), 映恩生物制药（苏州）有限公司 (中国江苏省苏州市苏州工业园区金谷路99号生物医药产业园三期B区项目3号楼301单元) filed a patent application (PCT/CN2025/102503) for "ANTI-CDH17 ANTIBODY-DRUG CONJUGATE AND USE THEREOF" on Jun 20, 2025. With publication no. WO/2025/261505, the det...